cache/e59099f781c9096116bb7212daf4adafd8e0bdb5e442fb868c4eefeff1bccf7b

COM:IONCTURA

Ionctura

  • Privately Held

Ionctura is a clinical-stage biotech company focused on the development of novel anti-cancer ion channel inhibitors. The company leverages its expertise in ion channel pharmacology to target difficult-to-treat cancers with a focus on solid tumors.

peer of

investor of